Clinical Trials in Maryland

Showing 11461-11480 of 19,983 trials

COMPLETEDNA8.3 miles

Growth and Tolerance of Infants Fed Formula for 16 Weeks

NCT03487094

Growth and Tolerance Trial of Iron-fortified infant formulas

Child Development

Nature's One216 participantsStarted Jul 2018

Tucson, Arizona, United States • Newport, Arkansas, United States • Searcy, Arkansas, United States +21 more locations

TERMINATEDPhase 2/317 miles

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

NCT02341560

This study will determine the effect of QPI-1007 on visual function in subjects with recent-onset NAION and assess the safety and tolerability of intravitreal injections of QPI-1007 in this population. This study will also evaluate the structural changes in the retina following administration of QPI-1007.

Non Arteritic Anterior Ischemic Optic Neuropathy

Quark Pharmaceuticals732 participantsStarted Feb 2016

Little Rock, Arkansas, United States • Loma Linda, California, United States • Los Angeles, California, United States +82 more locations

Growth and Tolerance of Infants Fed Formula for 16 Weeks

Phase 2/3, Randomized, Double-Masked, Sham-Controlled Trial of QPI-1007 in Subjects With Acute Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)

Find Trials by Condition in Maryland

The New England Bladder Cancer Study

A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagnosed, Stage III Subjects With Locally Advanced, Unresectable Non-small Cell Lung Cancer

Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)

A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2

Transnasal Therapy for Acute Migraine Attack

Single Dose Truvada Study

Cognitive Behavior Therapy for Insomnia (CBT-I) in Persons With Traumatic Brain Injury (TBI)

Bronchial Thermoplasty 10+ Year Study

Midostaurin Access Program for Newly Diagnosed FLT3 (ITD or TKD) Mutated AML Adult Patients Eligible for Standard Induction and Consolidation Chemotherapy

Abemaciclib With or Without Atezolizumab in Metastatic Castration Resistant Prostate Cancer

Phase 2B Extension Study of Ataluren (PTC124) in Duchenne/Becker Muscular Dystrophy (DMD/BMD)

Intra-oral Treatment of OLP With Rivelin®-CLO Patches

A Study of Rovalpituzumab Tesirine Administered in Combination With Nivolumab and With or Without Ipilimumab for Adults With Extensive-Stage Small Cell Lung Cancer

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

Study of APL-1202 in Non-Muscle Invasive Bladder Cancer Patients Who Are Resistant to One Induction Course of BCG Treatment

ACR | LAB Urine Analysis Test System Evaluation of Performance

Follow up Study to Assess Long Term Safety and Outcomes in Infants and Children Born to Mothers Participating in Retosiban Treatment Studies

A Study to Look at the Efficacy and Safety of Keppra® Extended Release Formulation - XR